Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $28.36 USD
Change Today +0.22 / 0.78%
Volume 1.4M
MDCO On Other Exchanges
Symbol
Exchange
Munich
NASDAQ GS
As of 8:10 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - medicines company (MDCO)

Name (Connections)Board RelationshipsTitleKey Developments
Robert Hugin MBA 43 RelationshipsIndependent Director and Chairman of Audit Committee 
Melvin Spigelman M.D. 43 RelationshipsIndependent Director and Member of Audit Committee 
Hiroaki Shigeta 14 RelationshipsIndependent Director, Member of Audit Committee and Member of Compensation Committee 
John Kelly 19 RelationshipsIndependent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee 

Compensation Committee* - medicines company (MDCO)

Name (Connections)Board RelationshipsTitle
Armin Kessler 37 RelationshipsIndependent Director and Member of Compensation Committee
Hiroaki Shigeta 14 RelationshipsIndependent Director, Member of Audit Committee and Member of Compensation Committee
Elizabeth Wyatt 19 RelationshipsLead Director and Chairman of Compensation Committee
MDCO Compensation vs. Industry
874.6K
443.6K
Chief Executive Officer
642.6K
293.6K
Chief Financial Officer
Share price activity for MEDICINES COMPANY (MDCO)
52 Week Price Performance
MDCO
Industry Average

Nominating Committee* - medicines company (MDCO)

Name (Connections)Board RelationshipsTitleKey Developments
Robert Savage M.B.A. 22 RelationshipsIndependent Director and Chairman of Nominating & Corporate Governance CommitteeThe Medicines Company Announces Management Changes, Effective March 3, 2014
02/24/14
John Kelly 19 RelationshipsIndependent Director, Member of Audit Committee and Member of Nominating & Corporate Governance CommitteeThe Medicines Company Announces Executive Appointments
09/18/12

Corporate Governance Committee* - medicines company (MDCO)

Name (Connections)Board RelationshipsTitle
John Kelly 19 RelationshipsIndependent Director and Member of Compensation Committee
Robert Savage M.B.A. 22 RelationshipsIndependent Director, Member of Audit Committee and Member of Compensation Committee
MDCO and Competitor
Insiders vs. External
Board
20%
80%
The Medicines Company
20%
80%
Integra LifeSciences Holdings Corporation
25%
75%
BTG plc
33%
67%
Skyepharma PLC
19%
81%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
22%
78%
KrKa dd Novo Mesto
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDCO:US $28.36 USD +0.22

MDCO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BTG PLC 709.50 GBp -14.00
Integra LifeSciences Holdings Corp $67.17 USD -0.97
Krka dd Novo mesto €68.02 EUR -0.08
Richter Gedeon Nyrt 4,600 +35.00
Skyepharma PLC 285.00 GBp -5.00
View Industry Companies
 

Industry Analysis

MDCO

Industry Average

Valuation MDCO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.7x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICINES COMPANY, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.